Chronic liver disease and oxidative stress–a narrative review

S Seen - Expert Review of Gastroenterology & Hepatology, 2021 - Taylor & Francis
Introduction: Oxidative stress underlies the pathophysiology of various etiologies of chronic
liver disease and contributes to the development of hepatocarcinogenesis. Areas covered …

Impact of sarcopenia and myosteatosis in non-cirrhotic stages of liver diseases: similarities and differences across aetiologies and possible therapeutic strategies

A Cespiati, M Meroni, R Lombardi, G Oberti… - Biomedicines, 2022 - mdpi.com
Sarcopenia is defined as a loss of muscle strength, mass and function and it is a predictor of
mortality. Sarcopenia is not only a geriatric disease, but it is related to several chronic …

High meat consumption is prospectively associated with the risk of non-alcoholic fatty liver disease and presumed significant fibrosis

D Ivancovsky-Wajcman, N Fliss-Isakov, LS Grinshpan… - Nutrients, 2022 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) has been associated with meat consumption in
cross-sectional studies. However, only a few prospective studies have been conducted, and …

Hepatitis C virus and the host: a mutual endurance leaving indelible scars in the host's immunity

MU Mondelli, S Ottolini, B Oliviero, S Mantovani… - International Journal of …, 2023 - mdpi.com
Hepatitis C virus (HCV) has spread worldwide, and it is responsible for potentially severe
chronic liver disease and primary liver cancer. Chronic infection remains for life if not …

Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis

I Cacciola, G Russo, R Filomia, C Pitrone… - Liver …, 2021 - Wiley Online Library
Background Data concerning the impact of hepatitis C virus (HCV) cure on type 2 diabetes
mellitus (T2DM) are controversial. The aim of the study was to evaluate the effects of anti …

Therapy of chronic viral hepatitis: the light at the end of the tunnel?

GM Saracco, A Marzano, M Rizzetto - Biomedicines, 2022 - mdpi.com
Chronic viral hepatitis determines significant morbidity and mortality globally and is caused
by three main etiological actors (Hepatitis B Virus, Hepatitis C Virus, and Hepatitis D Virus) …

[HTML][HTML] Cardioprotective effect of antiviral therapy among hepatitis C infected patients: A meta-analysis

V Jaiswal, SP Ang, M Hanif, M Jha, V Kumar… - IJC Heart & …, 2023 - Elsevier
Abstract Background Hepatitis C (HCV) infections have been shown to be associated a with
higher risk of atherosclerotic cardiovascular disease (CVD). However, the use of antiviral …

Hepatitis C virus clearance with sofosbuvir/daclatasvir regime improves oxidative stress of diabetic status in HCV patients by regulating NF-κB/Nrf2 mRNA expression

A El-Hameed, A Mohamed - Egyptian Journal of Chemistry, 2022 - ejchem.journals.ekb.eg
Background: HCV eradication improves both hepatic and non-hepatic outcomes, as well as
metabolic disorders like insulin resistance and type 2 diabetes. Aim: The study's purpose is …

Effect of HCV eradication by DAAs on liver steatosis, carotid atherosclerosis, and associated metabolic comorbidities: A systematic review

A Cespiati, I Coelho Rodrigues, I Santos… - Liver …, 2024 - Wiley Online Library
Abstract Background and Aims The beneficial effect of Hepatitis C virus (HCV) eradication
by direct antiviral agents (DAAs) on liver fibrosis is well defined. Despite this, the impact of …

Plasma inflammatory biomarkers associated with advanced liver fibrosis in HIV–HCV-coinfected individuals

X Chen, X Liu, S Duan, R Tang, S Zhou, R Ye… - International Journal of …, 2020 - mdpi.com
Background: HIV and HCV coinfection leads to accelerated liver fibrosis, in which microbial
translocation and systemic inflammation might play important roles. Objective: This study …